BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25322986)

  • 1. DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.
    Chu Q; Han N; Yuan X; Nie X; Wu H; Chen Y; Guo M; Yu S; Wu K
    J Hematol Oncol; 2014 Oct; 7():73. PubMed ID: 25322986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DACH1 is a cell fate determination factor that inhibits cyclin D1 and breast tumor growth.
    Wu K; Li A; Rao M; Liu M; Dailey V; Yang Y; Di Vizio D; Wang C; Lisanti MP; Sauter G; Russell RG; Cvekl A; Pestell RG
    Mol Cell Biol; 2006 Oct; 26(19):7116-29. PubMed ID: 16980615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression of DACH1 and cyclin D1 in endometrial cancer.
    Nan F; Lü Q; Zhou J; Cheng L; Popov VM; Wei S; Kong B; Pestell RG; Lisanti MP; Jiang J; Wang C
    Cancer Biol Ther; 2009 Aug; 8(16):1534-9. PubMed ID: 19502783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.
    Han N; Yuan X; Wu H; Xu H; Chu Q; Guo M; Yu S; Chen Y; Wu K
    Oncotarget; 2015 Mar; 6(8):5877-88. PubMed ID: 25788272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
    Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
    Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dachshund binds p53 to block the growth of lung adenocarcinoma cells.
    Chen K; Wu K; Cai S; Zhang W; Zhou J; Wang J; Ertel A; Li Z; Rui H; Quong A; Lisanti MP; Tozeren A; Tanes C; Addya S; Gormley M; Wang C; McMahon SB; Pestell RG
    Cancer Res; 2013 Jun; 73(11):3262-74. PubMed ID: 23492369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
    Zhang T; Zheng J; Jiang N; Wang G; Shi Q; Liu C; Lu Y
    Cancer Lett; 2009 Sep; 283(1):59-67. PubMed ID: 19380190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
    Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
    Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organoid modelling identifies that DACH1 functions as a tumour promoter in colorectal cancer by modulating BMP signalling.
    Hu X; Zhang L; Li Y; Ma X; Dai W; Gao X; Rao X; Fu G; Wang R; Pan M; Guo Q; Xu X; Zhou Y; Gao J; Zhang Z; Cai S; Peng J; Hua G
    EBioMedicine; 2020 Jun; 56():102800. PubMed ID: 32512510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DACH1 regulates macrophage activation and tumour progression in hypopharyngeal squamous cell carcinoma.
    Li W; Xu L; Cao J; Ge J; Liu X; Liu P; Teng Y; Wang S; Sun Y; Liu M; Tian L
    Immunology; 2023 Oct; 170(2):253-269. PubMed ID: 37243970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.
    Karim S; Al-Maghrabi JA; Farsi HM; Al-Sayyad AJ; Schulten HJ; Buhmeida A; Mirza Z; Al-Boogmi AA; Ashgan FT; Shabaad MM; NourEldin HF; Al-Ghamdi KB; Abuzenadah A; Chaudhary AG; Al-Qahtani MH
    BMC Cancer; 2016 Sep; 16(Suppl 2):741. PubMed ID: 27766950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of DACH1, a novel Wnt signaling component in colorectal cancer.
    Yan W; Wu K; Herman JG; Brock MV; Fuks F; Yang L; Zhu H; Li Y; Yang Y; Guo M
    Epigenetics; 2013 Dec; 8(12):1373-83. PubMed ID: 24149323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
    Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
    Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor signaling regulates Dach1 expression during skeletal development.
    Horner A; Shum L; Ayres JA; Nonaka K; Nuckolls GH
    Dev Dyn; 2002 Sep; 225(1):35-45. PubMed ID: 12203718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMP6 Regulates Proliferation and Apoptosis of Human Sertoli Cells Via Smad2/3 and Cyclin D1 Pathway and DACH1 and TFAP2A Activation.
    Wang H; Yuan Q; Sun M; Niu M; Wen L; Fu H; Zhou F; Chen Z; Yao C; Hou J; Shen R; Lin Q; Liu W; Jia R; Li Z; He Z
    Sci Rep; 2017 Apr; 7():45298. PubMed ID: 28387750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin is a JAK2 and ERK1/2 effector that can promote renal tumor cell proliferation under hypoxic conditions.
    Miyake M; Goodison S; Lawton A; Zhang G; Gomes-Giacoia E; Rosser CJ
    J Hematol Oncol; 2013 Sep; 6():65. PubMed ID: 24004818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis.
    Liu Q; Li A; Yu S; Qin S; Han N; Pestell RG; Han X; Wu K
    J Hematol Oncol; 2018 Apr; 11(1):53. PubMed ID: 29636079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling.
    Pan XW; Chen L; Hong Y; Xu DF; Liu X; Li L; Huang Y; Cui LM; Gan SS; Yang QW; Huang H; Qu FJ; Ye JQ; Wang LH; Cui XG
    Int J Oncol; 2016 Jun; 48(6):2580-90. PubMed ID: 27035563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing DACH1 promotes esophageal cancer growth by inhibiting TGF-β signaling.
    Wu L; Herman JG; Brock MV; Wu K; Mao G; Yan W; Nie Y; Liang H; Zhan Q; Li W; Guo M
    PLoS One; 2014; 9(4):e95509. PubMed ID: 24743895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.